1. Antibodies combining the peptide a sequence of the first class (MICA) histocompatibility enhancing complex (MHC); used to produce effective drugs for cancer treatment.

摘要

The present disclosure provides, in part, compositions comprising peptides immunospecifically binds to defined binding partners, wherein the peptides comprise at least complementarity determining regions relating to the complementarity regions shown in Table 1.